Clinical trial

Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants

NCT00349726 · NICHD Neonatal Research Network, Other · Completed

Key facts

NCT number NCT00349726
Title Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Official title Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Acronym INS-1
Lead sponsor NICHD Neonatal Research Network, Other
Collaborators National Eye Institute (NEI) NIH National Center for Research Resources (NCRR) Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Status Completed
Phase Phase 2
Study type Interventional
Conditions Infant, Newborn, Low Birth Weight, Small for Gestational Age, Premature, Retinopathy of Prematurity, Bronchopulmonary Dysplasia (BPD)
Intervention type Drug
Interventions Inositol lower volume, Inositol higher volume, Placebo lower volume, Placebo higher volume
Enrollment 74
Start date Jun 1, 2006
Primary completion Dec 1, 2007
Completion Dec 1, 2007
First posted Jul 10, 2006
Last update posted Jun 20, 2017
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies